Skip to main navigation Skip to search Skip to main content

Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma

Project: Research

Project Details

AcronymELMUMY
StatusActive
Effective start/end date1 Jan 2023 → 31 Dec 2026

Collaborative partners

  • Leibniz University Hannover
  • National and Kapodistrian University of Athens (NKUA) (lead)
  • Biomedical Research Foundation of the Academy of Athens (BRFAA)
  • National Hellenic Research Foundation
  • University of Turin
  • University of Navarra
  • Mosaiques Diagnostics GmbH
  • Centre national de la recherche scientifique (CNRS)
  • Université Montpellier
  • Marios Lymarakis Kai Sia EE
  • Universitätsklinikum Würzburg
  • Cyprus Foundation for Muscular Dystrophy Research
  • Atos IT Solutions and Services Iberia S.L.
  • Atos SA

Funding type

  • EU funding

Funding scheme

  • EU-HEU: Health: RIA

Access Project